R&D channel feed – Endpoints News

R&D channel feed

J&J's BCMA/CD3 bispecific nabs a conditional EMA nod, jumping in front of FDA

3 years ago

VistaGen faces another fail as anxiety drug flops a PhIII study — shares crater

3 years ago

'Like a bulletproof vest': Cancer cells make their own kind of collagen. Can piercing through make treatments better?

3 years ago

Small UK biotech touts long-term data for hemophilia B gene therapy as it attempts a comeback

3 years ago

Roche trims out some pipeline failures while flagging a PhIII flop for Tecentriq

3 years ago

Pfizer to make major investment in vaccine R&D and manufacturing site in New York

3 years ago

X4 slashes pipeline, lays off staff just three weeks after netting a $55M PIPE

3 years ago

John McHutchison throws in the towel on HBV drug, triggering layoffs as Assembly shifts to next-gen approaches

3 years ago

Microcap biotech's shares crater on a PhIII failure for heavy drinking drug

3 years ago

Without voluntary withdrawals, ODAC to review two more dangling accelerated approvals

3 years ago

Scoop: AbbVie terminates early-stage study of I-Mab's antibody, another clinical setback in CD47 field

3 years ago

Updated: Small cannabinoid biotech says its CMO was hit with cyberattack, resulting in clinical trial delays

3 years ago

Keytruda hit with second PhIII setback this year as Merck's blockbuster flops certain head and neck trial

3 years ago

Bristol Myers vets tie up another all-stock deal, lining up clinical-stage oncology pipeline

3 years ago

Gene therapy for ovarian cancer fails PhIII study — sinking biotech's shares

3 years ago

MDMA psychotherapy trial put on pause after Health Canada inspection

3 years ago

Amgen, GSK, Regenxbio and others urge SCOTUS to review 'damaging' decision on biomedical patents

3 years ago

As the pandemic high wanes, Inovio chops headcount again while chasing Covid win

3 years ago

Lynparza fails a PhIII test in colorectal cancer, cutting off big R&D avenue for Merck and AstraZeneca

3 years ago

Editas hires top Sanofi scientist for CMO as C-suite shuffle continues

3 years ago

Sesen Bio pauses bladder cancer drug work, offloads eye disease antibodies to Roche

3 years ago

Eliem delays a depression trial, indefinitely postpones another after blaming CMC issues for low drug exposure

3 years ago

Kyowa Kirin pulls the plug on drug development for successor to Parkinson's drug Nourianz

3 years ago

As Big Pharma loses interest in new antibiotics, infections are only growing stronger

3 years ago

First page Previous page 127 128 129130131 132 133 Next page Last page